Stay updated with breaking news from Nasdaq Ctic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CTI BioPharma (NASDAQ:CTIC – Get Rating)‘s stock had its “buy” rating reiterated by stock analysts at JMP Securities in a report issued on Monday, TipRanks reports. They presently have a $6.00 target price on the biopharmaceutical company’s stock. JMP Securities’ price objective would indicate a potential upside of 11.52% from the stock’s current price. CTIC […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CEO Adam R. Craig sold 27,000 shares of the business’s stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $6.00, for a total transaction of $162,000.00. Following the completion of the transaction, the chief executive officer now owns 16,678 shares […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has earned an average rating of “Buy” from the nine research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the company. The […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has been assigned a consensus rating of “Buy” from the nine research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have assigned a buy rating to the company. The […]
Wall Street analysts predict that CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) will post earnings of $0.18 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for CTI BioPharma’s earnings. The highest EPS estimate is $0.38 and the lowest is ($0.02). CTI BioPharma reported earnings of ($0.23) per share in […]